The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00893854 |
Recruitment Status : Unknown
Verified May 2009 by Shahid Beheshti University of Medical Sciences.
Recruitment status was: Recruiting
First Posted : May 6, 2009
Last Update Posted : May 6, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Uveitis Cystoid Macular Edema | Drug: Diclophenac Drug: Triamcinolone | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema |

Arm | Intervention/treatment |
---|---|
Experimental: Diclophenac |
Drug: Diclophenac |
Experimental: Triamcinolone |
Drug: Triamcinolone |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- cystoids macular edema which is diagnosed by OCT and flurocein angiography
- 5/200 < Visual acuity < 20/50
- resistance to routine treatment (oral treatment, periocular injection)
Exclusion Criteria:
- history of retinal disease cause macular edema like diabetes
- arterial occlusion
- monocular patients
- patients candidate for intra-ocular operation
- history of glaucoma or ocular hypertension
- any cataract that would interfere with OCT

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00893854
Iran, Islamic Republic of | |
Ophthalmic Research Center | Recruiting |
Tehran, Iran, Islamic Republic of, 166666 | |
Contact: Masoud Soheilian, MD +98 21 22585952 labbafi@hotmail.com |
ClinicalTrials.gov Identifier: | NCT00893854 |
Other Study ID Numbers: |
8727 |
First Posted: | May 6, 2009 Key Record Dates |
Last Update Posted: | May 6, 2009 |
Last Verified: | May 2009 |
Macular Edema Uveitis Edema Macular Degeneration Retinal Degeneration Retinal Diseases Eye Diseases Uveal Diseases Triamcinolone Diclofenac Anti-Inflammatory Agents Glucocorticoids |
Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Antirheumatic Agents Cyclooxygenase Inhibitors |